Worth reading
44Recurring
Scored from 1 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Adjustment to exercise prices
Terms of the stock acquisition rights
Exercise price
Series 11: ¥73.8 before adjustment and ¥25.8 after adjustment. Series 12: ¥82 before adjustment and ¥28.7 after adjustment. The floor under the adjustment provision is Not disclosed.
Stock Split RatioSeries 11: increased from 100 to 286 underlying shares per right. Series 12: increased from 100 to 285. Applicable from 30 March 2026.
Most recent equity financing
Issuance of new shares and Series 14 and Series 15 Stock Acquisition Rights through a third-party allotment approved on 26 February 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Adjustment to exercise prices |
| Exercise price | Series 11: ¥73.8 before adjustment and ¥25.8 after adjustment. Series 12: ¥82 before adjustment and ¥28.7 after adjustment. The floor under the adjustment provision is Not disclosed. |
| Stock Split Ratio | Series 11: increased from 100 to 286 underlying shares per right. Series 12: increased from 100 to 285. Applicable from 30 March 2026. |
| Most recent equity financing | Issuance of new shares and Series 14 and Series 15 Stock Acquisition Rights through a third-party allotment approved on 26 February 2026 |
Items this document does not state (24)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The issuance of new shares and stock acquisition rights through a third-party allotment met the conditions for adjustment of the exercise prices stipulated in the terms of issue of the Series 11 and Series 12 Stock Acquisition Rights.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.